In reference to the recent mayo clinic “study” in which 24 overweight women were found to have valvular heart disease, all of whom had been on “phen-phen” an average of ten months, consider the following:
- In the 24 and 30 years respectively that phentermine and fen fluramine have been available including almost ten years of combination therapy, not a single case of valvular heart disease had been reported; and yet within a few months, 24 cases were found all living within a 200 mile radius of one another within one half of the cases reported by one physician.
- No “Study” was ever done, according to Mayo, a “Serendipitious observation based on physician communication.” A “Perceived Association.”
- These are probably closer to 25 million patients on these medications (18 million prescriptions/month not including physicians who dispense and thousands of patients on these medications continuously for 3 and 4 years or longer).
- Has anyone examined the possibility of a contaminant (remember tryptophan, an amino-acid used for insomnia? A contaminated batch from a single distributor caused some people to develop edsinophilic myalgic syndrome, a rare side effect causing muscular and neurologic symptoms.) Tryptophan has never returned to health food store shelves.
- What about the possibility of an infectious agent?
- Rumors of credibility, politics, drug manufacturing and patents may also need to be investigated and further evaluated.
- Most importantly, a prospective medical study needs to be done to obtain valid objective results.
Individual results may vary with treatment.